In vivo performance of injectable self-hardened synthetic bone cement (osteopaste) as a filler for bone defects
A new injectable self-hardened synthetic bone cement (Ostepaste) was developed for filling bone defects. The major component of Osteopaste was limestone which consisted of tetra-calcium phosphate (TTCP) and tri-calcium phosphate (TCP) powder. Osteopaste showed good potential for clinical application...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Conference or Workshop Item |
Language: | English English |
Published: |
2019
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/71826/1/Proof.pdf http://irep.iium.edu.my/71826/2/2-Si2TE%202019%20Poster%20-%20cnz%20edited%203.pdf http://irep.iium.edu.my/71826/ http://techkem.com.my/sirim-invention-innovation-technology-expo-si2te-2019-on-16th-18th-april-2019-at-kulim-hi-tech-park-kedah/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Islam Antarabangsa Malaysia |
Language: | English English |
Summary: | A new injectable self-hardened synthetic bone cement (Ostepaste) was developed for filling bone defects. The major component of Osteopaste was limestone which consisted of tetra-calcium phosphate (TTCP) and tri-calcium phosphate (TCP) powder. Osteopaste showed good potential for clinical applications as it was shown biocompatible, osteoconductive and osteointegration. |
---|